1. Home
  2. CNTX vs PAAI Comparison

CNTX vs PAAI Comparison

Compare CNTX & PAAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Context Therapeutics Inc.

CNTX

Context Therapeutics Inc.

HOLD

Current Price

$0.38

Market Cap

47.7M

Sector

Health Care

ML Signal

HOLD

PAAI

Paradium.AI Inc. Common Stock

N/A

Current Price

$1.42

Market Cap

49.5M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
CNTX
PAAI
Founded
2015
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
47.7M
49.5M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
CNTX
PAAI
Price
$0.38
$1.42
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$6.60
N/A
AVG Volume (30 Days)
1.7M
4.1M
Earning Date
05-08-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
17.39
191.93
EPS
N/A
N/A
Revenue
N/A
$16,892,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
27.46
52 Week Low
$0.34
$0.87
52 Week High
$3.62
$3.47

Technical Indicators

Market Signals
Indicator
CNTX
PAAI
Relative Strength Index (RSI) 38.40 55.66
Support Level $0.34 $0.87
Resistance Level $0.70 N/A
Average True Range (ATR) 0.02 0.56
MACD 0.01 0.11
Stochastic Oscillator 73.14 25.00

Price Performance

Historical Comparison
CNTX
PAAI

About CNTX Context Therapeutics Inc.

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Share on Social Networks: